Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

TLR9 anticorps (AA 868-1016)

TLR9 Reactivité: Humain IHC, ELISA, FACS, ICC Hôte: Souris Monoclonal 1B12H2 unconjugated
N° du produit ABIN5542492
  • Antigène Voir toutes TLR9 Anticorps
    TLR9 (Toll-Like Receptor 9 (TLR9))
    Épitope
    • 18
    • 15
    • 8
    • 6
    • 6
    • 5
    • 4
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 868-1016
    Reactivité
    • 92
    • 38
    • 11
    • 7
    • 6
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    Humain
    Hôte
    • 61
    • 31
    • 8
    • 7
    • 1
    Souris
    Clonalité
    • 70
    • 38
    Monoclonal
    Conjugué
    • 59
    • 13
    • 13
    • 8
    • 5
    • 4
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp TLR9 est non-conjugé
    Application
    • 71
    • 46
    • 44
    • 42
    • 22
    • 14
    • 10
    • 9
    • 6
    • 5
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    Immunohistochemistry (IHC), ELISA, Flow Cytometry (FACS), Immunocytochemistry (ICC)
    Fonction
    TLR9 Antibody
    Purification
    Purified antibody
    Immunogène
    Purified recombinant fragment of human TLR9 (AA: 868-1016) expressed in E. Coli.
    Clone
    1B12H2
    Isotype
    IgG2a
  • Indications d'application

    ELISA: 1/10000

    FCM: 1/200 - 1/400

    ICC: 1/200 - 1/1000

    Restrictions
    For Research Use only
  • Validation #103693 (Immunofluorescence)
    'Independent Validation' signe
    by
    Klinik für Anästhesie, Intensivmedizin und Schmerztherapie, Universitätsklinikum der Ruhr Universität Bochum
    No.
    #103693
    Date
    26.03.2019
    Antigène
    TLR9
    Numéro du lot
    160127
    Application validée
    Immunofluorescence
    Contrôle positif

    U937 monocytic cells

    Contrôle négative

    No primary antibody control

    Conclusion

    Passed. ABIN5542492 localization on ER is visible. Negative control without primary antibody shows no signal.

    'Independent Validation' signe
    Validation Images
    Protocole
    Anticorps primaire
    ABIN5542492
    Anticorps secondaire
    AF488-conjugated AffiniPure alpaca anti-Mouse IgG antibody (Jackson ImmunoResearch, 615-545-214)
    Full Protocol
    • Grow U937 cells in RPMI (Gibco, 21875-034) supplemented with 10% FCS (Gibco, A3840001) and Pen/Strep(Gibco, 15140-122), at 37°C and 5% CO2 in 500µL in 12-well plates.
    • Use cytospin to spin cells onto slide.
    • Fix cells on coverslide in 4% PFA for 20min at RT.
    • Wash cells 3x for 5min with PBS.
    • Permeabilize cells in PBS containing 0.1% Triton for 5min at RT.
    • Block non-specific binding with Duolink PLA Blocking Solution (Sigma) for 30 min at RT.
    • Incubate cells with primary mouse anti-TLR9 antibody (antibodies-online, ABIN5542492, lot 160127) diluted 1:200 in staining solution ON at 4°C.
    • Wash cells 3x for 5min with PBS.
    • Incubate cells with secondary AF488-conjugated AffiniPure alpaca anti-Mouse IgG antibody (Jackson ImmunoResearch, 615-545-214) diluted 1:400 in staining solution for 1h at RT.
    • Wash cells 2x for 5min with PBS.
    • Mount coverslips on glass slides in ProLong Gold antifade reagent (Invitrogen, P36935,1890418) containing DAPI.
    • Image acquisition with an Olympus widefield microscope.
    Notes

    TLR9 staining using ABIN5542492 shows typical localization peri-nuclear localization.

  • Validation #103821 (Proximity Ligation Assay)
    'Independent Validation' signe
    by
    Klinik für Anästhesie, Intensivmedizin und Schmerztherapie, Universitätsklinikum der Ruhr Universität Bochum
    No.
    #103821
    Date
    29.04.2019
    Antigène
    TLR9
    Numéro du lot
    160127
    Application validée
    Proximity Ligation Assay
    Contrôle positif

    U937 monocytic cells stimulated with ODN1826

    Contrôle négative

    Anti TLR9 antibody (ABIN5542492) alone

    Anti pY antibody (ABIN361758) alone

    Conclusion

    Passed. PLA signal visible in stimulated cells. Negative control with only one primary antibody shows no signal.

    'Independent Validation' signe
    Validation Images
    Protocole
    Anticorps primaire
    ABIN5542492
    Anticorps secondaire
    ABIN361758
    Full Protocol
    • Grow U937 cells in RPMI (Gibco, 21875-034) supplemented with 10% FCS (Gibco, A3840001) and Pen/Strep(Gibco, 15140-122), at 37°C and 5% CO2 in 500µL in 12-well plates.
    • Incubate the cells with 1µM ODN1826 for 4h.
    • Use cytospin to spin cells onto slide.
    • Fix cells on coverslide in 4% PFA for 20min at RT.
    • Wash cells 3x for 5min with PBS.
    • Permeabilize cells in PBS containing 0.1% Triton for 5min at RT.
    • Block non-specific binding with Duolink PLA Blocking Solution (Sigma-Aldrich) for 30min at RT.
    • Incubate cells with primary mouse anti-TLR9 antibody (antibodies-online, ABIN5542492, lot 160127) diluted 1:200 and primary rabbit anti-pY antibody (antibodies-online, ABIN361758, lot 1508290) diluted 1:100 ON at 4°C.
    • Wash cells 3x for 5min with PBS.
    • Incubate cells with Duolink In Situ PLA Probe anti-Rabbit MINUS (Sigma-Aldrich, DUO92005, lot SLBZ4516) and Duolink In Situ PLA Probe anti-Mouse mouse PLUS (Sigma-Aldrich, DUO92001, lot SLBZ8369) proximity probes according to manufacturers recommendations.
    • Wash cells 2x for 5min with PBS.
    • Perform Ligation step according to the Duolink PLA kit (Sigma).
    • Perform Amplification step according to the Duolink In Situ PlA Detection Kit Green (Sigma-Aldrich, DUO92014).
    • Mount coverslips on glass slides in ProLong Gold antifade reagent (Invitrogen, P36935, lot 1890418) containing DAPI.
    • Image acquisition with an Olympus widefield microscope.
    Notes

    We used double the amount the Phi29 polymerase for the amplifaction step than recommended.

  • Format
    Liquid
    Buffer
    Purified antibody in PBS with 0.05 % sodium azide.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C,-20 °C
    Stockage commentaire
    Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
  • Antigène
    TLR9 (Toll-Like Receptor 9 (TLR9))
    Autre désignation
    TLR9 (TLR9 Produits)
    Synonymes
    anticorps CD289, anticorps toll like receptor 9, anticorps toll-like receptor 9, anticorps TLR9, anticorps Tlr9
    Sujet

    Description: The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns (PAMPs) that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. This gene is preferentially expressed in immune cell rich tissues, such as spleen, lymph node, bone marrow and peripheral blood leukocytes. Studies in mice and human indicate that this receptor mediates cellular response to unmethylated CpG dinucleotides in bacterial DNA to mount an innate immune response.

    Aliases: CD289

    Poids moléculaire
    115.8kDa
    ID gène
    54106
    HGNC
    54106
    UniProt
    Q9NR96
    Pathways
    Signalisation TLR, Activation of Innate immune Response, Cellular Response to Molecule of Bacterial Origin, Toll-Like Receptors Cascades
Vous êtes ici:
Support technique